GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Nasmed Ozel Saglik Hizmetleri Ticaret AS (IST:EGEPO) » Definitions » Research & Development

Nasmed Ozelglik Hizmetleri Ticaret AS (IST:EGEPO) Research & Development : ₺0.0 Mil (TTM As of Dec. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Nasmed Ozelglik Hizmetleri Ticaret AS Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Nasmed Ozelglik Hizmetleri Ticaret AS's Research & Development for the three months ended in Dec. 2024 was ₺0.0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2024 was ₺0.0 Mil.

Nasmed Ozelglik Hizmetleri Ticaret AS Research & Development Historical Data

The historical data trend for Nasmed Ozelglik Hizmetleri Ticaret AS's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nasmed Ozelglik Hizmetleri Ticaret AS Research & Development Chart

Nasmed Ozelglik Hizmetleri Ticaret AS Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Research & Development
Get a 7-Day Free Trial - - - - -

Nasmed Ozelglik Hizmetleri Ticaret AS Quarterly Data
Dec18 Dec19 Mar20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Nasmed Ozelglik Hizmetleri Ticaret AS Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₺0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nasmed Ozelglik Hizmetleri Ticaret AS  (IST:EGEPO) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Nasmed Ozelglik Hizmetleri Ticaret AS Research & Development Related Terms

Thank you for viewing the detailed overview of Nasmed Ozelglik Hizmetleri Ticaret AS's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

Nasmed Ozelglik Hizmetleri Ticaret AS Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Nasmed Ozel Saglik Hizmetleri Ticaret AS (IST:EGEPO) » Definitions » Research & Development
Comparable Companies
IST:LKMNH IST:TNZTP HCA SAU:4013 XTER:FRE SZSE:300015 XTER:FME XKLS:5225 THC BOM:543220 UHS DVA NSE:APOLLOHOSP BSP:RDOR3 BKK:BDMS EHC CHE ADX:PUREHEALTH ENSG BOM:532843
Traded in Other Exchanges
N/A
Address
Iller Bankasi Halide Edip Adivar Bulvar, 507. Sk. No:3, Izmir, TUR, 35270
Website
https://www.egepolhastanesi.com
Nasmed Ozel Saglik Hizmetleri Ticaret AS provides quality healthcare services. It arranges consultations, travel planning, accommodation, translation, and other relevant services for its patients 24/7.

Nasmed Ozelglik Hizmetleri Ticaret AS Headlines

No Headlines